Product/Composition:- | Pramipexole |
---|---|
Strength:- | ER tab: 0.375 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg; IR Tab: 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg |
Form:- | Tablets |
Reference Brands:- | Mirapex®(US), Sifrol® (EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Pramipexole, a dopamine agonist for Parkinson’s and RLS, is available as 0.125–4.5 mg tablets. Brands include Mirapex® and Sifrol®. Pharma B2B platforms provide bulk access to GMP-certified Pramipexole with global regulatory compliance and consistent supply for hospitals, neurology practices, and pharmaceutical distributors.
Pramipexole is a dopamine agonist used in the treatment of Parkinson’s disease and restless legs syndrome (RLS). It is available in both immediate- and extended-release oral tablet forms with strengths ranging from 0.125 mg to 4.5 mg. Marketed under brands like Mirapex® in the US and Sifrol® in the EU, Pramipexole helps improve motor function and reduce symptoms in neurological disorders. Pharma B2B suppliers offer bulk procurement of Pramipexole from GMP-certified manufacturers, ensuring quality, regulatory compliance, and efficient global supply. Ideal for pharmacies, distributors, and hospital procurement across neurology and chronic care specialties.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications